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Virion-associated proteinEight accessory proteins have been identiﬁed in severe acute respiratory syndrome-associated coronavirus
(SARS-CoV). They are believed to play roles in the viral life cycle and may contribute to the pathogenesis and
virulence. ORF9b as one of these accessory proteins is located in subgenomic mRNA9 and encodes a 98 amino
acid protein. However, whether 9b protein is a structural component of SARS-CoV particles remains
unknown. In this study, we demonstrate that 9b protein is translated from bicistronic mRNA9 via leaky
ribosome scanning and it is incorporated into both virus-like particles (VLPs) and puriﬁed SARS-CoV virions.
Further analysis shows that sufﬁcient incorporation of 9b protein into VLPs is dependent upon the co-
expression of E and M proteins, but not upon the presence of either S or N protein. Our data indicate that 9b
protein of SARS-CoV is another virion-associated accessory protein. This ﬁnding will lead to a better
understanding of the properties of the SARS-CoV 9b protein.© 2009 Elsevier Inc. All rights reserved.Introduction
Severe acute respiratory syndrome (SARS) which broke out in
2002–2003 has caused worldwide panic due to its high mortality in
humans (Peiris et al., 2004). In 2003, SARS-associated coronavirus
(SARS-CoV) was identiﬁed as the aetiological agent for this disease
(Drosten et al., 2003; Ksiazek et al., 2003; Peiris et al., 2003). The
genome of SARS-CoV is a plus-stranded single RNA which is 29,727
nucleotides in length excluding the polyadenylation tract at the 3′ end
(Rota et al., 2003). Fourteen ORFs have been identiﬁed, which
translate into two replicative polyproteins (pp1a and pp1ab), 4
structural proteins (S, E, M, N) and 8 accessory proteins (3a, 3b, 6, 7a,
7b, 8a, 8b, 9b) (Marra et al., 2003; Rota et al., 2003). The accessory
proteins are unique to SARS-CoV, as they have little homology in
amino acid sequence with accessory proteins of other coronaviruses.t fax: +86 21 54921011. B. Sun,
hanghai, Chinese Academy of
225 South Chongqing Road,
sibs.ac.cn (B. Sun).
ll rights reserved.All current studies concerning accessory proteins of coronaviruses
including SARS-CoV suggest that they are not essential for virus rep-
lication (de Haan et al., 2002; Yount et al., 2005), but do affect virus
release, stability, pathogenesis, and ﬁnally contribute to the virulence
(Weiss and Navas-Martin, 2005). Understanding the properties and
functions of SARS-CoV speciﬁc accessory proteins may help to explain
the differences in pathogenicity between SARS-CoV and other known
coronaviruses.
Among the 8 accessory proteins of SARS-CoV, 3a protein was ﬁrst
found to be a structural component of SARS-CoV virions as it was
incorporated into puriﬁed virions and virus-like particles (Ito et al.,
2005; Shen et al., 2005). Our previous study also shows that 3a protein
functions as an ion channel to facilitate virus release (Lu et al., 2006). In
addition, ORF7a protein was also characterized as a virion-associated
protein of SARS-CoV (Huang et al., 2006a), which induces apoptosis
((Kopecky-Bromberg et al., 2006; Tan et al., 2004) and arrests the cell
cycle when over-expressed (Yuan et al., 2006). Subsequently, both
SARS-CoV ORF6 and ORF7b proteins were determined to be incorpo-
rated into virus particles(Huang et al., 2007; Schaecher et al., 2007).
ORF6 proteinwas further reported to function as an IFN antagonist and
to accelerate replication of a related mouse virus (Kopecky-Bromberg
et al., 2007; Tangudu et al., 2007). Four other accessory proteins have
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virions and have important functions (Tan et al., 2006).
There are nine subgenomic mRNAs in SARS-CoV, four of which
(mRNA3, 7, 8 and 9) are bicistronic producing two ORFs initiating at
the ﬁrst or additional downstream start codon (Thiel et al., 2003;
Weiss and Navas-Martin, 2005). On bicistronic mRNA9, a 98 amino
acid viral accessory protein, 9b, is encoded from a complete internal
ORF within the N gene. The expression of ORF9b has been detected in
infected cells and in clinical specimens (Chan et al., 2005). Anti-9b
antibodies have also been found in the serum of SARS patients (Qiu
et al., 2005). The crystal structure additionally indicates that 9b
protein is an unusual membrane binding protein with a long
hydrophobic lipid-binding tunnel. It was therefore proposed to be
associated with intracellular vesicles and may have function in SARS-
CoV assembly (Meier et al., 2006). However, further analysis of 9b
protein is necessary for understanding its contribution in the viral life
cycle.
In this study, we have examined the expression mechanism of 9b
protein from mRNA9. We ﬁnd that 9b protein is translated via a leaky
ribosomal scanning mechanism. Furthermore, we provide the ﬁrst
evidence that 9b protein is present both in virus-like particles and in
puriﬁed virions, and that the efﬁcient incorporation of 9b protein is
dependent upon the co-expression of E and M proteins. These data
suggest that 9b protein is not only a viral accessory protein but also a
structural component of SARS-CoV virions.
Results
Translation of ORF9b via leaky ribosomal scanning
Our previous study using a proteomics approach has identiﬁed
ORF3a as a viral protein of SARS-CoV (Zeng et al., 2004). Meanwhile,
several peptides belonging to ORF9b protein had also been detected in
the cytosol of SARS-CoV infected Vero E6 cells (Data not shown). To
further investigate the properties of SARS-CoV 9b protein, puriﬁed
recombinant 9b protein was used to produce both anti-9b polyclonal
and monoclonal antibodies. The expression of 9b protein in SARS-CoV
infected cells was conﬁrmed by Western blot analysis with anti-9b
monoclonal antibody. An 11 kDa protein (9b protein) was recognized
in infected but not in uninfected cells (Fig. 1B left). The speciﬁcity was
further ensured by immunoprecipitation with anti-9b polyclonal
antibody. The complex precipitated was resolved under gel electro-
phoresis and the corresponding band was submitted to mass
spectrometry. A peptide: “AFQSTPIVVQMTK” representing amino
acids 69–81 of the SARS-CoV 9b protein was identiﬁed (Fig. 1B right).
As none of the previous studies has illustrated the expression
mechanism of 9b protein, we then examined whether 9b protein was
able to be translated from subgenomic mRNA9 alone and how it was
translated. The 9b protein encoded by an internal ORF starts at the
18th nucleotide downstream of the transcription regulatory sequence
of mRNA9 (Thiel et al., 2003). The start codon for ORF9b is very close
to the start codon for ORFN, with only 10 nucleotides in between (Fig.
1A). To conﬁrm that 9b protein can be translated from an mRNA
corresponding to the SARS-CoV subgenomic RNA9, the sequence
encoding ORFN which contains ORF9b was cloned into the eukaryotic
expression vector pCAGGS and transfected into 293T cells. The results
showed that 9b protein was able to be expressed in cells transfected
with plasmids containing the N gene coding region (Fig. 1C ORFN), but
that the expression level was relatively weaker compared with that of
cells transfected with ORF9b alone (Fig. 1C ORF9b). When the ORF9b
initiation codon was mutated from ATG to ACG (Fig. 1C N(9b−)), 9b
protein was not expressed while the expression level of N protein
showed little change. When the ORFN initiation codon was mutated
from ATG to ATC (Fig. 1C N(N−)), N protein was not expressed while
the expression level of 9b protein dramatically increased. These data
not only demonstrated the expression of 9b protein from the N genecoding region, but also led us to further investigate the translation
regulatory mechanism for 9b protein.
The downstream ORF of multicistronic mRNA is mainly translated
by leaky scanning ribosomes or internal ribosome entry (Kozak, 1989;
Thiel and Siddell, 1994; van Vliet et al., 2002). Analysis of the sequence
ﬂanking the initiation codon of ORFN and ORF9b showed that the
initiation of the N gene represented a suboptimal Kozak context (A at
−3, T at +4), while the initiation of the 9b gene indicated an optimal
Kozak context (A at−3, G at +4) (Kozak, 1986). In addition, a lower
expression level of 9b protein had been observed already in cells
transfected with ORFN and then in cells transfected with ORF9b or N
(N−). All of these ﬁndings make it reasonable to presume that the
translation initiation of ORF9b is regulated by a leaky ribosomal
scanningmechanism underwhich the downstream gene expression is
affected by the translation efﬁciency of the upstream gene (Kozak,
1987, 1989). To test this, a more ideal Kozak context was induced in
ORFN (Fig. 1C ORFN +4T to G). We detected an obviously decreased
expression level of 9b protein as expected. Meanwhile, when the
Kozak context of ORFN was changed to a much weaker one (Fig. 1C
ORFN−3A to C), an increased expression of 9b protein was observed.
Together, these data suggest that ORF9b protein is translated via a
leaky ribosomal scanning mechanism.
ORF9b protein is present in SARS-CoV VLPs
In order to examine whether 9b protein is incorporated into virus
particles, we established a SARS-CoV VLP system in vitro to study the
presence of 9b protein in virus-like particles.
To ensure that the release of 9b protein is associated with virus
particles, we ﬁrst examined whether 9b protein was able to be
released from cells expressing 9b protein alone. Cells were transfected
with pCAGGS-9b plasmid. Parental pCAGGS-3a or vector alone was
also transfected as control. Western blot analysis of the cell lysates
clearly showed that both 3a and 9b proteins were expressed (Fig. 2).
The clariﬁed culture supernatants from 9b and 3a-expressing cells and
control cells were applied to the top of a 20% sucrose cushion for
puriﬁcation. Western blot analysis of the pellets demonstrated that 9b
protein was not released into the culture medium of 9b-expressing
cells, while 3a protein was released as previously described (Huang et
al., 2006b). The abundant host protein, actin, was not detectable in the
supernatants from any group of cells (Fig. 2).
We then transfected pCAGGS-S, pCAGGS-E, pCAGGS-M, pCAGGS-N
(9b−) and pCAGGS-9b simultaneously into 293T cells. At 48 h post
transfection, the culture mediumwas collected and clariﬁed. The VLPs
puriﬁed with 20% sucrose were then added to the top of a 20–60%
continuous sucrose gradient for fractionation. Twelve fractions were
collected, and each was examined by Western blot analysis. The
results showed that 9b protein was released from the VLP system, and
exhibited in fractions 5 to 9 along with S, N, and M proteins (Fig. 3).
The densities of these fractions were approximately between 1.12 g/
ml and 1.20 g/ml. The greatest amount of 9b protein was detected in
fraction 7 (density, 1.16 g/ml), which also contained the highest level
of S, N andM proteins. The data suggest that 9b protein is incorporated
into virus-like particles containing S, N, M and E proteins. E protein
was not detectable in Western blot due to its low abundance in SARS-
CoV VLPs (Huang et al., 2006a).
ORF9b protein is incorporated into puriﬁed SARS-CoV virions
To further conﬁrm the potential association of 9b protein with
SARS-CoV virions, puriﬁed SARS-CoV was prepared from the super-
natant of virus-infected FRhK-4 cells. The medium was collected at
36 h post infection, at which time the cells remained intact and CPE
had not appeared. Clariﬁed supernatant was then subjected to sucrose
gradient ultracentrifugation as described above and twelve fractions
from top to bottom were collected and analyzed. The results showed
Fig. 2. ORF9b protein is not released from 9b-expressing cells. 293T cells were
transfected with pCAGGS-3a-HA (3a), pCAGGS (vector), or pCAGGS-9b (9b) indepen-
dently. At 48 h post transfection, supernatants were clariﬁed, applied to a 20% sucrose
cushion, and centrifuged at 100,000 ×g for 3 h at 4 °C. The pellets were suspended in
1×SDS-PAGE loading buffer (Medium). Cell lysates were prepared with 1×SDS-PAGE
loading buffer (Cell). Samples were subjected to Western blot analysis with anti-HA
antibody to detect 3a protein (37 kDa), anti-9b antibody (11 kDa) to detect 9b protein
and anti-actin antibody for internal control.
Fig. 1. Expression of 9b protein from mRNA9. (A) SARS-CoV mRNA9 organization. ORFN, ORF9b, frameshift and transcription-regulating sequence (TRS), are shown. Black box
represents RNA leading sequence. ORFN is highlighted in blue, while ORF9b is shown in an enlarged representation highlighted in green. TRS sequence is marked by underlines and in
grey. Start codon of ORFN and 9b are shown in corresponding colors, adapted from (Meier et al., 2006; Thiel et al., 2003). (B) Left. 11 kDa 9b protein was detected in SARS infected
FRhK-4 cells by anti-9b monoclonal antibody, but not in uninfected cells. β-actin was detected in both infected and uninfected cells. Right. 9b protein was immunoprecipitated by
anti-9b polyclonal antibody from SARS infected FRhK-4 cell lysates in RIPA buffer, the mass spectrometry analysis of the corresponding gel slices detected a speciﬁc peptide that
represents 9b protein. (C) Translation of ORF9b by leaky ribosomal scanning. Schematic diagram of cDNA constructs is shown (upper panel). Wild-type ORF9b sequence (ORF9b),
wild-type N gene sequence (ORFN), a point mutation eliminating 9b initiation codon in ORFN sequence (N(9b−)), a point mutation eliminating N initiation codon (N(N−)), an
optimal Kozak context around the ORFN initiation codon (ORFN +4T to G), and a weaker Kozak context around the ORFN initiation codon (ORFN −3A to C). 293T cells were
transfected with plasmids encoding the indicated cDNAs and analyzed byWestern blot with both anti-N and anti-9b monoclonal antibodies for each sample. β-actinwas detected by
actin speciﬁc polyclonal antibody.
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1.16 g/ml) to 10 (density, 1.20 g/ml) at the same time (Fig. 4). The
peak of the 9b protein was detected in fraction 8 along with the
highest level of S, N and M proteins. The density of fraction 8 was
approximately 1.18 g/ml, consistent with the density of SARS-CoV
particles (Huang et al., 2006a; Ito et al., 2005; Schaecher, Mackenzie,
and Pekosz, 2007). These data further suggest that 9b protein is
incorporated into SARS-CoV virions.
Incorporation of 9b protein into VLPs is inﬂuenced by E and M proteins
As 9b protein is present in virions, it is advantageous to char-
acterize the role of other SARS-CoV structural proteins in incorpora-
tion of 9b protein into VLPs. Cultures of 293T cells were transfected
with the indicated plasmids, and pCAGGS vector was added to adjust
the total amount of DNA to equivalent levels. As shown in Fig. 5, in the
Fig. 5. Release of SARS-CoV 9b protein in the presence of other viral structural proteins.
9b protein was co-expressed with E protein, M protein, S protein, and N protein in
different combinations in 293T cells, as indicated. The quantity of each plasmid for this
analysis was same, and total DNA levels were adjusted by adding pCAGGS. At 48 h post
transfection, medium was harvested and pelleted through a 20% sucrose cushion.
Medium (Medium) and cell lysates (Cell) were analyzed for S protein (S), N protein (N),
M protein (M), and 9b protein (9b) by Western blotting. S, N, and 9b proteins were
detected using indicated monoclonal antibodies, while M protein with HA tag was
detected using anti-HA antibody.
Fig. 3. Presentation of 9b protein in SARS-CoV VLPs. Subconﬂuent 293T cells were
transfected with 3 μg of pCAGGS-S, 3 μg of pCAGGS-N(9b−), 3 μg of pCAGGS-M, 3 μg of
pCAGGS-E and 3 μg of pCAGGS-9b each. At 48 h post transfection, culture mediumwas
harvested and clariﬁed. The released VLPs were ﬁrst pelleted by centrifugation through
a 20% sucrose cushion, and then further puriﬁed over a 20–60% sucrose gradient. Twelve
fractions were collected from top to bottom; each fraction concentrated by 20% sucrose
ultracentrifugation was analyzed using Western blot analysis with anti-S monoclonal
antibody (S), anti-N monoclonal antibody (N), anti-HA tag monoclonal antibody (M),
and anti-9b monoclonal antibody (9b). β-actinwas detected by actin speciﬁc polyclonal
antibody (Actin). The density of each fraction was measured and is shown.
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pCAGGS-E and pCAGGS-9b, a low level of 9b protein was detected
suggesting that 9b protein is able to be released when only E protein is
available. A marked increase of 9b protein in culture medium was
observed when M protein was co-expressed with 9b and E proteins.
The amount of 9b protein in VLPs did not change signiﬁcantly when S
or N, or both of them were added. The results indicate that sufﬁcient
incorporation of 9b protein into SARS-CoV VLPs is dependent upon co-Fig. 4. Incorporation of 9b protein into puriﬁed SARS-CoV virions. Clariﬁed supernatant
from SARS infected cells was subjected to 20% sucrose ultracentrifugation. The pellets
resuspended in NTE buffer were further applied on a 20–60% sucrose gradient cushion.
Twelve fractions were collected from top to bottom after ultracentrifugation, each
fraction was condensed using 20% sucrose and subjected to Western blot analysis with
anti-S monoclonal antibody (S), anti-N monoclonal antibody (N), anti-M polyclonal
antibody (M) and anti-9b monoclonal antibody (9b). β-actin was detected by actin
speciﬁc polyclonal antibody (Actin). The density of each fraction was measured and is
shown.expression of E and M proteins but is not inﬂuenced by either S or N
protein.
The effect of 9b protein on VLP production was further analyzed.
VLPs containing S, E, M and N proteins in 9b-expressing cells and non-
expressing cells were examined and compared. Unfortunately, no
obvious differences in the assembly of these proteins have been
detected (Fig. 5).
Discussion
As a newly emerging coronavirus in the human, SARS-CoV has led
to acute inﬂammation and a lethal syndrome in patients. Phylogenetic
analysis showed that SARS-CoV had been classiﬁed as group 2b CoV
distantly related to known group 2 CoV (Gorbalenya et al., 2004;
Snijder et al., 2003). The functions of viral replicase and four basic
structural proteins (S, E, M, and N) of SARS-CoV are similar to those of
other coronaviruses. However, the accessory proteins of SARS-CoV
show little homology to those of known coronaviruses. The speciﬁc
properties of these accessory proteins may contribute to the
differences in pathogenicity between SARS-CoV and other corona-
viruses. In this report, we demonstrate that SARS-CoV 9b protein is
another viral accessory protein incorporated into virus particles. Our
ﬁnding makes 9b protein the ﬁfth accessory protein of SARS-CoV to be
found present in virions.
For efﬁcient utilization of their limited genome, viruses frequently
use bicistronic RNAs to produce alternative open reading frames.
SARS-CoV ORF1b, ORF3b, ORF7b, ORF8b, and ORF9b are all transcribed
via alternative open reading frames. In addition to ORF7b protein
(Schaecher et al., 2007), ORF9b protein is another accessory protein
that is proven to be translated via leaky ribosomal scanning. Other
283K. Xu et al. / Virology 388 (2009) 279–285virus accessory proteins encoded by multicistronic mRNAs are
translated either by leaky ribosomal scanning or by internal entry of
the ribosome (Senanayake and Brian, 1997; Thiel and Siddell, 1994).
The mechanisms must be identiﬁed individually.
After the ﬁrst SARS-CoV accessory protein, 3a, had been identiﬁed
as a structural component of virions, accessory proteins 7a, 7b, and 6
were subsequently determined to be incorporated into virions (Huang
et al., 2006a, 2007; Ito et al., 2005; Schaecher et al., 2007; Shen et al.,
2005). Here, our data further indicate that 9b protein is the ﬁfth
virion-associated accessory protein of SARS-CoV to be recognized.
Analysis of VLPs and puriﬁed SARS-CoV particles showed that the
highest level of 9b proteinwas detected in the fractions also abundant
in S, N, and M proteins. While this property is almost equivalent
among these accessory structural proteins, they do exhibited different
biochemical characteristics. Some, such as 3a and 6 proteins, are
released from expressing cells, while others, like 7a and 9b proteins,
are not detectable in the supernatant of expressing cells. As a result,
the release of the protein itself is seen not to be a determinant of
incorporation. The localization of these proteins to intracellular vesicle
components like Golgi and ER may help them to be incorporated
throughmechanisms bringing them close to the site of virus assembly.
The mechanism of incorporating accessory proteins into virus par-
ticles is still not well understood and must be further studied.
Furthermore, it will be important to address the necessity of
incorporation of all these accessory proteins into virions.
Release of 9b protein was detected from cells co-expressing E and
9b proteins, but not from cells expressing 9b protein alone. This result
was similar to what was found with 7a protein; the release of these
two accessory proteins with E protein may be caused by their
incorporation into putative E protein-containing vesicles (Maeda
et al., 1999; Huang et al., 2006a). When M protein but not S or N
protein was added, the release of 9b into the medium was increased
markedly, indicating that E and M proteins are sufﬁcient to allow
incorporation of 9b protein into virus-like particles. This is consistent
with former studies showing that E andM proteins could form smooth
virus-like particles when co-expressed, while S and N were unneces-
sary for VLP formation (Hsieh et al., 2005; Mortola and Roy, 2004). As
we do not have evidence for interactions between 9b and E or M
proteins, we cannot determine whether the incorporation of 9b
protein into VLPs generated by E and M co-expressing cells is caused
by the physical associations among them. However, this mechanism
requires further examination.
ORF9b on SARS-CoV bicistronic mRNA9 is a fully internal ORF in
the N gene coding region. There are also coordinate proteins similar to
SARS-CoV 9b which are so-called “Internal” or “I” proteins in other
group II coronaviruses (Fischer et al., 1997; Lapps et al., 1987;
Senanayake and Brian, 1997). In MHV, I protein is an accessory viral
structural protein which can contribute to plaque morphology
(Fischer et al., 1997). In our study, I protein of SARS-CoV (9b protein)
was also shown to be a structural component of the virions. It is
reasonable to propose that 9b protein of SARS-CoVmay also play a role
in the viral life cycle. However, a more thorough functional analysis of
9b protein still must be performed. Although a recent study with
SARS-CoV accessory protein deletion mutants showed little effect on
pathogenicity in a mouse model (Dediego et al., 2008), these acces-
sory proteins, including 9b protein, may still play a supportive role in
the viral life cycle in patients.
Materials and methods
Cell culture, transfection, and virus infection
293T, Vero E6 and FRhK-4 cells (ATCC) were cultured in Dulbecco's
modiﬁed Eagle's medium (DMEM) containing 10% fetal bovine serum
(Gibco) at 37 °C in a CO2 incubator. Lipofectamine (Invitrogen) was
applied for transient transfection following the manufacturer'sprocedure. For SARS-CoV infection, FRhK-4 cells were inoculated
with virus (GZ 50 Strain) as previously described (Zhong et al., 2003)
at MOI of 5 for 1 h in medium without FBS. After 1 h, the cells were
washed with medium and cultured with complete medium for the
required time. All procedures with SARS-CoV infection were per-
formed in a biosafety level-3 laboratory.
Plasmids
Viral RNAwas extracted from ﬁltered supernatant of virus-infected
FRhK-4 cells using the RNesay Mini Kit (Qiagen) following the
manufacturer's protocol. The cDNA was prepared by reverse tran-
scription using M-MLV reverse transcriptase (Invitrogen) with
oligonucleotide primers. S, E, M, N, 3a and 9b genes were ampliﬁed
by PCR with speciﬁc primer using Pyrobest polymerase (Takara). S, N
and 9b genes were cloned directly into pCAGGS vector under a
powerful chicken β-actin promoter (kindly provided by Dr. Jun-ichi
Miyazaki, Osaka University). The deletion of ORFN (N(N−)) was
obtained by mutating the initiation codon of N gene from ATG to ATC,
while the deletion of ORF9b (N(9b−)) in the N gene coding regionwas
achieved by mutating the initiation codon of ORF9b from ATG to ACG.
For the mutation of the KOZAK context, primers containing the
mutated nucleotides (−3A to C, +4T to G) were synthesized to
amplify the expected ORFs and then cloned into pCAGGS vector. E, M
and 3a genes were ﬁrst cloned into pcDNA-3′HA (Invitrogen), and
then the genes together with HA tag at the 3′ end were ampliﬁed by
PCR and subcloned into the pCAGGS vector. All plasmids were
conﬁrmed by sequence analysis.
Antibodies
The monoclonal and polyclonal antibodies against 9b protein were
both produced by the Antibody Research Centre, Shanghai Institute of
Biological Science. Mouse anti-S and mouse anti-N antibodies were
also produced by the Antibody Research Centre, Shanghai Institute of
Biological Science. Rabbit anti-M antibody (AP6008b) was purchased
from Abgent. Mouse anti-HAmonoclonal antibody was obtained from
Covance and rabbit anti-actin from Sigma. HRP-conjugated anti-
mouse IgG was purchased from Sigma and HRP-conjugated anti-
rabbit IgG from Southern Biotech.
Mass spectrometry
Samples were treated as previously described (Zeng et al., 2004).
Brieﬂy, the infected cell lysates, which had been immunoprecipitated
using 9b polyclonal antibody, were subjected to SDS-PAGE and the
corresponding gel slices were excised and digested with trypsin. The
digested peptides were analyzed by mass spectrometry (LCQ Deca XP
Plus, Thermo Finnigan). Data analysis was carried out using a shot-gun
approach.
Ultracentrifugation
For SARS-CoV puriﬁcation, the supernatant containing the virus
was inactivated with 1:2000 formaldehyde at 4 °C for 72 h as
previously described (Qu et al., 2005). For the SARS-CoV virus-like
particle system, the medium was collected 48 h post co-transfection
for S, E, M, N and 9b. The inactivated virus and the medium from the
VLP systemwere ﬁrst puriﬁed by centrifugation at 1000 ×g for 15 min
at 4 °C and then by ultracentrifugation over a 20% sucrose cushion at
100,000 ×g for 3 h in an SW41 ultracentrifuge rotor (Beckman). The
pellets were resuspended in NTE buffer (100 mM NaCl, 10 mM Tris–
HCl [pH7.5], 1 mM EDTA) and loaded onto a 20–60% continuous
sucrose gradient for fractionation at 100,000 ×g over 12 h at 4 °C in a
SW41 rotor (Hsieh et al., 2005; Mortola and Roy, 2004). Twelve
fractions from top to bottom were collected and concentrated
284 K. Xu et al. / Virology 388 (2009) 279–285separately by ultracentrifugation at 100,000 ×g for 3 h. Each pellet was
then dissolved in 1×SDS-PAGE loading buffer and analyzed by
Western blot assay.
To determine whether 9b protein is released from cells expressing
9b protein, supernatants from cells transfected with ORF3a, ORF9b or
empty vector were clariﬁed by centrifugation at 1000 ×g for 15 min at
4 °C. This was followed by ultracentrifugation over 20% sucrose at
100,000 ×g for 3 h in a SW41 rotor. The pellet was dissolved in 1×SDS-
PAGE loading buffer and submitted to Western blot analysis.
Immunoprecipitation and Western blot analysis
FRhK-4 cells were infected with SARS-CoV at 24 h post infection
and the cell lysates were collected as described previously (Lu et al.,
2006). Brieﬂy, infected cells were lysed with solution containing
40 mM Tris (pH 8.3) and 0.5% NP-40 at 22 °C for 5 min. The
supernatant was collected and subjected to immunoprecipitation and
Western blot assay. Clariﬁed supernatant was then incubated with
anti-9b polyclonal antibody together with 5% BSA and protein A/G
beads at 4 °C overnight. After immunoprecipitation, beads were
washed 5 times with RIPA buffer; the complex was eluted and
submitted to mass spectrometry analysis.
Expression of the SARS-CoV proteins in 293Tcells was studied 24 h
after transient transfection. The cells were lysed in SDS loading buffer
and subjected to SDS-PAGE electrophoresis. Proteins were transferred
to a nitrocellulose membrane and detected using corresponding
antibodies.
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